Find your next paid study

Ohio State UniversityNCT07447687

~$150 – $3,000

Actual pay is set by the research site.

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

This is a prospective, single-arm, open-label feasibility trial conducted at the MD Anderson Sarcoma Center and Cardio-Oncology Clinic. The study will enroll y…

Sarcoma,Soft Tissue

M.D. Anderson Cancer CenterNCT07874828

~$75 – $2,000

Actual pay is set by the research site.

Breast CancerSupportive Care in Cancer

Cardioprotective Effects of Empagliflozin in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study

The primary objective of this pilot study is to evaluate the feasibility and acceptability of a clinical trial protocol investigating 10 mg/day empagliflozin i…

Virginia Commonwealth UniversityNCT07883512

~$75 – $2,000

Actual pay is set by the research site.

Type 2 Diabetes Mellitus (T2DM)

A Randomized, Double-blind, Placebo-controlled Study Investigating the Effect of ALN-4324 on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM

Alnylam PharmaceuticalsNCT07465224

~$75 – $2,800

Actual pay is set by the research site.

EpilepsyFunctional Neurological DisorderMild Cognitive Impairment+5 more

Exercise Testing for Neurological Conditions

The goal of this study is to investigate how a one-time exercise session influences different parameters of brain function in people with neurological diseases…

Brigham and Women's HospitalNCT07883720

~$10 – $750

Actual pay is set by the research site.

Phase 3

TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events * Ev…

Transthyretin Amyloidosis With Cardiomyopathy

Alnylam PharmaceuticalsNCT07052903

~$50 – $2,100

Actual pay is set by the research site.

Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D)…

Type 2 Diabetes

Biomea Fusion Inc.NCT07502508

~$75 – $2,800

Actual pay is set by the research site.

DystoniaPediatricDeep Brain Stimulation+1 more

Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia

The goal of this study is to understand the development and progression of childhood dystonia, a movement disorder, in children. The main questions it aims to …

Children's Hospital Medical Center, CincinnatiNCT07325175

~$10 – $675

Actual pay is set by the research site.

Comparative Efficacy, Safety, and Efficiency of SYSTEM 1 Versus SYSTEM 2 Pulse Field Ablation Systems for Atrial Fibrillation Ablation Randomized Controlled Trial

This study randomizes patients undergoing PFA for A Fib to one of two standard care PFA systems. The patient will have an ICM placed to continuously monitor th…

AF - Atrial Fibrillation

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07883629

~$10 – $1,125

Actual pay is set by the research site.

Higher Risk Myelodysplastic Syndromes

Bexmarilimab Plus Azacitidine in a Randomized, Double-blind, Placebo-controlled Phase IIb Trial in Treatment-naïve Higher-risk Myelodysplastic Syndromes (HR-MDS)

This Phase IIb study (BEXERA) will evaluate the safety and efficacy of bexmarilimab (FP-1305), an antibody targeting Clever-1, given in combination with azacit…

Faron Pharmaceuticals LtdNCT07672769

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase 1/1b Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 436 as Monotherapy and in Combination With Other Therapies in Participants With Microsatellite Instability-high (MSI-H)/Mismatch Repair Deficient (dMMR) Solid Tumors

The primary objectives of this trial are to evaluate the safety profile of AMG 436 and to determine the maximum tolerated dose (MTD) and/or the recommended dos…

Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)

~$150 – $4,500

Actual pay is set by the research site.

AmgenNCT07403721

Fluid Guided Heart Failure Treatment

FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention. The goal of this pilot is to assess the perform…

Heart Failure